Detalhe da pesquisa
1.
Launching an International Community of Practice in Hematology/Oncology Medical Education.
Am Soc Clin Oncol Educ Book;
44(3): e100046, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776483
2.
The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer.
Front Oncol;
14: 1336546, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476371
3.
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy.
Front Oncol;
14: 1306311, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384808
4.
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Clin Lung Cancer;
24(8): 689-695.e1, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880074
5.
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
J Clin Oncol;
41(35): 5448-5472, 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820295
6.
Immune-Related Adverse Events in Patients with Lung Cancer.
Curr Oncol Rep;
25(11): 1259-1275, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782426
7.
Brief report: risk stratification following curative therapy for stage I NSCLC.
Front Oncol;
13: 1250315, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645428
8.
Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status.
Cancer;
129(22): 3546-3553, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548029
9.
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Cancer Treat Res Commun;
36: 100743, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531736
10.
Trends in participant race and sex reporting in lung cancer phase III clinical trials.
Cancer Rep (Hoboken);
6 Suppl 1: e1856, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421166
11.
First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non-Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report.
JTO Clin Res Rep;
4(7): 100536, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456921
12.
Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?
Clin Lung Cancer;
24(7): e237-e241, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336713
13.
Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer.
Cancers (Basel);
15(11)2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296863
14.
Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3.
Clin Lung Cancer;
24(7): 591-597, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365076
15.
When not having a tissue may not be an issue in advanced lung cancer.
Chin Clin Oncol;
12(4): 32, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355810
16.
From Boring to Bravo! Using Learning Science to Create Memorable Presentations.
Am Soc Clin Oncol Educ Book;
43: e389392, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196216
17.
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.
Cancers (Basel);
15(2)2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672426
18.
Using social media for patient-driven cancer research.
Nat Rev Cancer;
23(1): 1-2, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357796
19.
Impact of Benzodiazepine Use on Length of Stay and 30-Day ED Visits among Hospitalized Hematopoietic Stem Cell Transplant Recipients.
South Med J;
115(12): 936-943, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455905
20.
Genomic landscape of lung adenocarcinomas in different races.
Front Oncol;
12: 946625, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36248982